Cargando…
MELK is a prognostic biomarker and correlated with immune infiltration in glioma
OBJECTIVE: Glioma accounts for the vast majority of primary brain tumors with inevitable recurrence and poor prognosis. Maternal embryonic leucine zipper kinase (MELK) is overexpressed in multiple human tumors and could activate a variety of oncogenic-associated signal pathways. However, its role in...
Autores principales: | Yang, Haiyan, Zhou, Huandi, Wang, Guohui, Tian, Lei, Li, Haonan, Zhang, Yufeng, Xue, Xiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637824/ https://www.ncbi.nlm.nih.gov/pubmed/36353126 http://dx.doi.org/10.3389/fneur.2022.977180 |
Ejemplares similares
-
A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma
por: Wang, Guohui, et al.
Publicado: (2021) -
A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment
por: Li, Haonan, et al.
Publicado: (2021) -
CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas
por: Wang, Bo, et al.
Publicado: (2022) -
Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma
por: Tan, Zilong, et al.
Publicado: (2022) -
Prognostic biomarker SYK and its correlation with immune infiltrates in glioma
por: Wang, Changxin, et al.
Publicado: (2023)